These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 22144583)
1. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Jurmeister S; Baumann M; Balwierz A; Keklikoglou I; Ward A; Uhlmann S; Zhang JD; Wiemann S; Sahin Ö Mol Cell Biol; 2012 Feb; 32(3):633-51. PubMed ID: 22144583 [TBL] [Abstract][Full Text] [Related]
2. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL. Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071 [TBL] [Abstract][Full Text] [Related]
3. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544 [TBL] [Abstract][Full Text] [Related]
4. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844 [TBL] [Abstract][Full Text] [Related]
5. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Howe EN; Cochrane DR; Richer JK Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518 [TBL] [Abstract][Full Text] [Related]
6. FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion. Gardberg M; Kaipio K; Lehtinen L; Mikkonen P; Heuser VD; Talvinen K; Iljin K; Kampf C; Uhlen M; Grénman R; Koivisto M; Carpén O PLoS One; 2013; 8(9):e74923. PubMed ID: 24086398 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro. Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway. Wang J; Liang S; Duan X J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231 [TBL] [Abstract][Full Text] [Related]
9. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5. Sundararajan V; Gengenbacher N; Stemmler MP; Kleemann JA; Brabletz T; Brabletz S Oncotarget; 2015 Sep; 6(29):27083-96. PubMed ID: 26334100 [TBL] [Abstract][Full Text] [Related]
10. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. Liu L; Qiu M; Tan G; Liang Z; Qin Y; Chen L; Chen H; Liu J J Transl Med; 2014 Nov; 12():305. PubMed ID: 25367080 [TBL] [Abstract][Full Text] [Related]
11. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73. Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Cochrane DR; Spoelstra NS; Howe EN; Nordeen SK; Richer JK Mol Cancer Ther; 2009 May; 8(5):1055-66. PubMed ID: 19435871 [TBL] [Abstract][Full Text] [Related]
13. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma. Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572 [TBL] [Abstract][Full Text] [Related]
14. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
15. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528 [TBL] [Abstract][Full Text] [Related]
16. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
17. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305 [TBL] [Abstract][Full Text] [Related]
18. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells. Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530 [TBL] [Abstract][Full Text] [Related]
19. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084 [TBL] [Abstract][Full Text] [Related]
20. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2. Zhang T; Wan JG; Liu JB; Deng M Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]